Aldesleukin Active Not Recruiting Phase 2 Trials for Neoplasms, Malignant Treatment

IndicationsStatusPurposePhase
Active Not RecruitingTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT01697527Gene and Vaccine Therapy in Treating Patients With Advanced Malignancies